As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$196,980 Vol.
31 may 2026
1800
Sí
1900
Sí
1925
Sí
1950
Sí
2000
No
2200
No
2400
No
$196,980 Vol.
1800
$4,781 Vol.
Sí
1900
$39,649 Vol.
Sí
1925
$9,810 Vol.
Sí
1950
$24,533 Vol.
Sí
2000
$86,567 Vol.
No
2200
$23,708 Vol.
No
2400
$7,931 Vol.
No
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Apr 28, 2026, 6:09 PM ET
Volumen
$196,980Fecha de finalización
31 may 2026Mercado abierto
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$196,980Fecha de finalización
31 may 2026Mercado abierto
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes